Last updated: March 2026
AOD-9604 is a synthetic peptide corresponding to amino acids 177–191 of human growth hormone — the C-terminal fragment responsible for fat metabolism. Unlike full HGH, it stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 levels or blood glucose. Research dosing is typically 500 mcg via subcutaneous injection. Approved as a supplement by Australia's TGA; not FDA-approved.
AOD-9604 is a synthetic peptide corresponding to amino acids 177-191 of the growth hormone sequence — the C-terminal fragment responsible for fat metabolism, isolated from the growth-promoting effects.
AOD-9604 directly stimulates the breakdown of stored fat (lipolysis) in adipose tissue, promoting fat loss without affecting lean muscle.
Unlike full HGH, AOD-9604 does not affect IGF-1 levels or blood glucose. This avoids the metabolic side effects associated with growth hormone.
AOD-9604 also inhibits the creation of new fat cells (lipogenesis), helping prevent fat accumulation during use.
Administered via subcutaneous injection. The peptide is stable and has a good safety profile in research models.
Research data on AOD-9604's fat loss mechanism.
Third-party tested compounds from Swiss Chems — one of the most trusted research suppliers.
Affiliate link — supports MeetPeptide at no extra cost. All Swiss Chems products include third-party lab testing certificates.
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
This page is for educational purposes only. AOD-9604 is not FDA approved. TGA approval is for Australia only. Always consult a healthcare provider.